Hyper-igd Syndrome
📧 Sign up to get email alerts when something new happens for Hyper-igd Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Canakinumab in Patients With Active Hyper-IgD Syndrome [Phase 2]
Phase 2 trial of canakinumab for active Hyper-IgD syndrome due to mevalonate kinase deficiency has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2007-03-01Clinical Trial Update: The Efficacy and Safety of ITF2357 in AIS [Phase 2]
Phase 2 clinical trial update evaluating ITF2357 (givinostat) for autoinflammatory syndromes, including Hyper-IgD syndrome, TNF receptor-ass…